ENG/中
美国
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Estrella Immunopharma
0.8785
+0.0470
5.65%
成交量:
1.71万
成交额:
1.50万
市值:
3,177.15万
市盈率:
-3.62
高:
0.8990
开:
0.8739
低:
0.8475
收:
0.8315
数据加载中...
总览
公司
新闻
公告
Estrella Immunopharma, Inc.盘中异动 临近午盘股价大涨5.10%
市场透视
·
昨天
Estrella Immunopharma, Inc.盘中异动 临近收盘股价大跌5.12%
市场透视
·
04-18
Estrella Immunopharma, Inc.盘中异动 股价大跌6.52%报0.796美元
市场透视
·
04-17
Estrella Immunopharma, Inc.盘中异动 临近午盘股价大涨6.29%
市场透视
·
04-15
Estrella Immunopharma, Inc.盘中异动 股价大跌6.91%报0.847美元
市场透视
·
04-11
Estrella Immunopharma, Inc.盘中异动 快速上涨5.30%报0.935美元
市场透视
·
04-10
Estrella Immunopharma, Inc.盘中异动 早盘股价大跌6.59%报0.817美元
市场透视
·
04-09
Estrella Immunopharma, Inc.盘中异动 急速下跌5.00%报0.836美元
市场透视
·
04-07
Estrella Immunopharma, Inc.盘中异动 股价大跌6.38%
市场透视
·
04-04
Estrella Immunopharma, Inc.盘中异动 大幅下跌5.06%
市场透视
·
04-03
Estrella Immunopharma, Inc.股价飙升15.49% 市值涨112.04万美元
市场透视
·
03-11
Estrella Immunopharma, Inc.盘中异动 大幅跳水8.84%
市场透视
·
03-11
Estrella Immunopharma, Inc.盘中异动 股价大涨5.88%报1.08美元
市场透视
·
03-06
Estrella Immunopharma, Inc.盘中异动 早盘快速下跌5.83%
市场透视
·
03-03
Estrella Immunopharma, Inc.盘中异动 早盘股价大涨5.19%报1.010美元
市场透视
·
02-28
Estrella Immunopharma, Inc.盘中异动 早盘股价大跌5.45%
市场透视
·
02-28
Estrella Immunopharma, Inc.盘中异动 股价大跌5.17%
市场透视
·
02-26
Estrella Immunopharma, Inc.盘中异动 早盘股价大跌6.78%报1.23美元
市场透视
·
02-25
Estrella Immunopharma, Inc.盘中异动 大幅跳水18.18%报1.21美元
市场透视
·
02-24
D. Boral Capital:维持Estrella Immunopharma(ESLA.US)评级,由买入调整至买入评级, 目标价由16.00美元调整至16.00美元。
金融界
·
02-22
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/ESLA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":0.8785,"timestamp":1745352000000,"preClose":0.8315,"halted":0,"volume":17137,"delay":0,"floatShares":9912119,"shares":36165589,"eps":-0.242472,"marketStatus":"已收盘","change":0.047,"latestTime":"04-22 16:00:00 EDT","open":0.8739,"high":0.899,"low":0.8475,"amount":14964.224073,"amplitude":0.061936,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.242472,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.8315,"volumeRatio":0.49192},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","floatShares":9912119,"roa":"-35.45%","roe":"-163.06%","lyrEps":-0.121236,"volumeRatio":0.49192,"shares":36165589,"dividePrice":0,"high":0.899,"amplitude":0.061936,"preClose":0.8315,"low":0.8475,"week52Low":0.63,"pbRate":"221.05","week52High":3.23,"institutionHeld":0,"latestPrice":0.8785,"eps":-0.242472,"divideRate":0,"volume":17137,"delay":0,"ttmEps":-0.242472,"open":0.8739,"prevYearClose":1.2,"prevWeekClose":0.7936,"prevMonthClose":0.927,"prevQuarterClose":0.927,"fiveDayClose":0.8749,"twentyDayClose":0.9898,"sixtyDayClose":1.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESLA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529536009","title":"Estrella Immunopharma, Inc.盘中异动 临近午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529536009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529536009?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 23:32","pubTimestamp":1745335951,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时32分,Estrella Immunopharma, Inc.股票出现波动,股价急速拉升5.10%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体涨幅为1.80%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233231aa2c7680&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422233231aa2c7680&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2528773024","title":"Estrella Immunopharma, Inc.盘中异动 临近收盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528773024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528773024?lang=zh_cn&edition=fundamental","pubTime":"2025-04-18 04:17","pubTimestamp":1744921052,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日04时17分,Estrella Immunopharma, Inc.股票出现波动,股价急速下跌5.12%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体涨幅为1.01%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。Estrella 的使命是利用人类免疫系统的进化力量来改变癌症和自身免疫性疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041804173394d924bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041804173394d924bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2528406221","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌6.52%报0.796美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528406221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528406221?lang=zh_cn&edition=fundamental","pubTime":"2025-04-17 00:06","pubTimestamp":1744819614,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日00时06分,Estrella Immunopharma, Inc.股票出现波动,股价大幅跳水6.52%。截至发稿,该股报0.796美元/股,成交量2.0928万股,换手率0.06%,振幅5.28%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为1.17%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417000655973a1f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417000655973a1f52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2527444246","title":"Estrella Immunopharma, Inc.盘中异动 临近午盘股价大涨6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527444246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527444246?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 23:36","pubTimestamp":1744731412,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日23时36分,Estrella Immunopharma, Inc.股票出现波动,股价快速上涨6.29%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.47%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415233652aa2c701a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415233652aa2c701a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2526154691","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌6.91%报0.847美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526154691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526154691?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 23:01","pubTimestamp":1744383660,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日23时01分,Estrella Immunopharma, Inc.股票出现异动,股价急速下跌6.91%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.63%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411230100a4564a1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411230100a4564a1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2526259636","title":"Estrella Immunopharma, Inc.盘中异动 快速上涨5.30%报0.935美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526259636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526259636?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 22:14","pubTimestamp":1744294498,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日22时14分,Estrella Immunopharma, Inc.股票出现波动,股价大幅拉升5.30%。截至发稿,该股报0.935美元/股,成交量2.9779万股,换手率0.08%,振幅10.95%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为1.73%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410221458a4550aa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410221458a4550aa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2526539842","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大跌6.59%报0.817美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526539842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526539842?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 21:47","pubTimestamp":1744206424,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时47分,Estrella Immunopharma, Inc.股票出现异动,股价大幅跳水6.59%。截至发稿,该股报0.817美元/股,成交量6862股,换手率0.02%,振幅6.59%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为1.91%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409214704a6b58765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409214704a6b58765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2525602980","title":"Estrella Immunopharma, Inc.盘中异动 急速下跌5.00%报0.836美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525602980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525602980?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 23:54","pubTimestamp":1744041282,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日23时54分,Estrella Immunopharma, Inc.股票出现异动,股价大幅下跌5.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为1.28%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407235442a6b2de28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407235442a6b2de28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2524073892","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524073892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524073892?lang=zh_cn&edition=fundamental","pubTime":"2025-04-04 21:45","pubTimestamp":1743774339,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日21时45分,Estrella Immunopharma, Inc.股票出现波动,股价快速跳水6.38%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.85%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404214539a6afb4b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404214539a6afb4b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2524926444","title":"Estrella Immunopharma, Inc.盘中异动 大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524926444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524926444?lang=zh_cn&edition=fundamental","pubTime":"2025-04-03 22:50","pubTimestamp":1743691820,"startTime":"0","endTime":"0","summary":"北京时间2025年04月03日22时50分,Estrella Immunopharma, Inc.股票出现波动,股价急速下挫5.06%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。其相关个股中,Protagenic Therapeutics, Inc.、Osr Holdings, Inc.、Aptevo Therapeutics Inc.涨幅较大,Aptevo Therapeutics Inc.、Protagenic Therapeutics, Inc.、Genprex, Inc.较为活跃,换手率分别为4253.22%、1834.11%、469.85%,振幅较大的相关个股有Protagenic Therapeutics, Inc.、Aptevo Therapeutics Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 ,振幅分别为85.90%、84.06%、49.32%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403225020a44cce0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403225020a44cce0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2518246742","title":"Estrella Immunopharma, Inc.股价飙升15.49% 市值涨112.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518246742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518246742?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 22:01","pubTimestamp":1741701702,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日22时01分,Estrella Immunopharma, Inc.股票出现波动,股价快速上涨15.49%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为1.56%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031122014298a3d102&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031122014298a3d102&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2518720833","title":"Estrella Immunopharma, Inc.盘中异动 大幅跳水8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518720833?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 00:22","pubTimestamp":1741623768,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时22分,Estrella Immunopharma, Inc.股票出现波动,股价快速下跌8.84%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。其相关个股中,Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃,换手率分别为3707.85%、3218.00%、951.39%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.,振幅分别为88.14%、78.32%、49.87%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002248964058fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002248964058fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2517298859","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.88%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517298859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517298859?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 04:36","pubTimestamp":1741206965,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时36分,Estrella Immunopharma, Inc.股票出现波动,股价大幅上涨5.88%。截至发稿,该股报1.08美元/股,成交量1.7955万股,换手率0.05%,振幅7.84%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体涨幅为1.92%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043605a2612c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043605a2612c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2516637380","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速下跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516637380?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 22:49","pubTimestamp":1741013384,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时49分,Estrella Immunopharma, Inc.股票出现波动,股价快速跳水5.83%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032249449637b1a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032249449637b1a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2514376386","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨5.19%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514376386?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 23:16","pubTimestamp":1740755776,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时16分,Estrella Immunopharma, Inc.股票出现波动,股价大幅拉升5.19%。截至发稿,该股报1.010美元/股,成交量1.0893万股,换手率0.03%,振幅1.04%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823161698968437&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823161698968437&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2514387460","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514387460?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 00:41","pubTimestamp":1740674497,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时41分,Estrella Immunopharma, Inc.股票出现异动,股价大幅跳水5.45%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004137a25699d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004137a25699d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2514517618","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514517618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514517618?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 22:48","pubTimestamp":1740581335,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时48分,Estrella Immunopharma, Inc.股票出现异动,股价大幅下跌5.17%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224856abddf181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224856abddf181&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2514182740","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大跌6.78%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514182740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514182740?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:45","pubTimestamp":1740494729,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时45分,Estrella Immunopharma, Inc.股票出现异动,股价急速跳水6.78%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。其相关个股中,Organovo Holdings, Inc.、Gt Biopharma, Inc.、Adial Pharmaceuticals, Inc涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为875.90%、636.03%、533.95%,振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.,振幅分别为100.27%、46.65%、33.50%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224530abdc81c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224530abdc81c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2513751722","title":"Estrella Immunopharma, Inc.盘中异动 大幅跳水18.18%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513751722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513751722?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 22:31","pubTimestamp":1740407517,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分,Estrella Immunopharma, Inc.股票出现异动,股价急速跳水18.18%。Estrella Immunopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Estrella Immunopharma, Inc.公司简介:Estrella Immunopharma Inc 是一家临床阶段的生物制药公司,开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法,用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223157a2521459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223157a2521459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2513909762","title":"D. Boral Capital:维持Estrella Immunopharma(ESLA.US)评级,由买入调整至买入评级, 目标价由16.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513909762","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513909762?lang=zh_cn&edition=fundamental","pubTime":"2025-02-22 00:51","pubTimestamp":1740156681,"startTime":"0","endTime":"0","summary":"D. Boral Capital:维持Estrella Immunopharma(ESLA.US)评级,由买入调整至买入评级, 目标价由16.00美元调整至16.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22005148320974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ESLA"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":72,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESLA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1740110400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ESLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ESLA","date":"2025-04-21","current":-3.241379,"percent":0.997222,"low":-10.568666,"twenty":-5.652744,"median":-4.670514,"eighty":-4.117325,"high":-3.104323,"avg":-4.977286,"sd":1.1873,"marketCap":28699347},"quantilePoints":[{"date":"2023-10-13","current":-4.972461,"twenty":-6.796753,"median":-5.384194,"eighty":-5.200498,"marketCap":55265934},{"date":"2023-10-20","current":-4.346628,"twenty":-5.624899,"median":-4.845774,"eighty":-4.503973,"marketCap":48310170},{"date":"2023-10-27","current":-4.814103,"twenty":-5.358857,"median":-4.766595,"eighty":-4.395592,"marketCap":53505872},{"date":"2023-11-03","current":-4.877446,"twenty":-5.358857,"median":-4.877446,"eighty":-4.546793,"marketCap":54209897},{"date":"2023-11-10","current":-4.085653,"twenty":-5.257507,"median":-4.829938,"eighty":-4.367404,"marketCap":45409589},{"date":"2023-11-17","current":-3.800607,"twenty":-5.219501,"median":-4.560729,"eighty":-4.142662,"marketCap":42241478},{"date":"2023-11-24","current":-4.914497,"twenty":-5.067477,"median":-4.560729,"eighty":-4.117325,"marketCap":49633737},{"date":"2023-12-01","current":-5.785861,"twenty":-5.257507,"median":-4.829938,"eighty":-4.244012,"marketCap":58434045},{"date":"2023-12-08","current":-4.18255,"twenty":-5.193333,"median":-4.719087,"eighty":-4.244012,"marketCap":42241478},{"date":"2023-12-15","current":-4.356823,"twenty":-5.067477,"median":-4.653087,"eighty":-4.244012,"marketCap":44001540},{"date":"2023-12-22","current":-4.321969,"twenty":-5.053915,"median":-4.560729,"eighty":-4.244012,"marketCap":43649527},{"date":"2023-12-29","current":-4.008277,"twenty":-5.005043,"median":-4.502348,"eighty":-4.203463,"marketCap":40481416},{"date":"2024-01-05","current":-4.043132,"twenty":-4.967839,"median":-4.461387,"eighty":-4.18255,"marketCap":40833429},{"date":"2024-01-12","current":-3.520313,"twenty":-4.949351,"median":-4.397024,"eighty":-4.086666,"marketCap":35553244},{"date":"2024-01-19","current":-3.555168,"twenty":-4.949351,"median":-4.37517,"eighty":-4.043132,"marketCap":35905256},{"date":"2024-01-26","current":-4.217405,"twenty":-4.914497,"median":-4.391678,"eighty":-4.043132,"marketCap":42593490},{"date":"2024-02-02","current":-4.217405,"twenty":-4.914497,"median":-4.356823,"eighty":-4.022309,"marketCap":42593490},{"date":"2024-02-09","current":-4.008626,"twenty":-4.879642,"median":-4.356475,"eighty":-4.008626,"marketCap":40484936},{"date":"2024-02-16","current":-3.79915,"twenty":-4.877446,"median":-4.314662,"eighty":-4.008277,"marketCap":38369342},{"date":"2024-02-23","current":-4.421106,"twenty":-4.852108,"median":-4.351551,"eighty":-4.008277,"marketCap":36976978},{"date":"2024-03-01","current":-4.46488,"twenty":-4.845774,"median":-4.356823,"eighty":-4.008556,"marketCap":37343087},{"date":"2024-03-08","current":-4.683308,"twenty":-4.845774,"median":-4.37517,"eighty":-4.008626,"marketCap":39169969},{"date":"2024-03-15","current":-4.508653,"twenty":-4.845774,"median":-4.391678,"eighty":-4.019572,"marketCap":37709196},{"date":"2024-03-22","current":-4.727519,"twenty":-4.845774,"median":-4.421106,"eighty":-4.038967,"marketCap":39539739},{"date":"2024-03-28","current":-5.471666,"twenty":-4.878324,"median":-4.421106,"eighty":-4.043132,"marketCap":45763587},{"date":"2024-04-05","current":-4.990159,"twenty":-4.946386,"median":-4.434042,"eighty":-4.068645,"marketCap":41736391},{"date":"2024-04-12","current":-4.771293,"twenty":-4.947572,"median":-4.461387,"eighty":-4.088693,"marketCap":39905848},{"date":"2024-04-19","current":-4.508653,"twenty":-4.946386,"median":-4.46488,"eighty":-4.106683,"marketCap":37709196},{"date":"2024-04-26","current":-4.552426,"twenty":-4.946123,"median":-4.508653,"eighty":-4.135548,"marketCap":38075304},{"date":"2024-05-03","current":-4.604954,"twenty":-4.927077,"median":-4.543309,"eighty":-4.168608,"marketCap":38514635},{"date":"2024-05-10","current":-4.683746,"twenty":-4.914497,"median":-4.525981,"eighty":-4.18255,"marketCap":39173630},{"date":"2024-05-17","current":-6.309978,"twenty":-4.927077,"median":-4.552426,"eighty":-4.18255,"marketCap":38441413},{"date":"2024-05-24","current":-6.009503,"twenty":-4.949351,"median":-4.552645,"eighty":-4.18255,"marketCap":36610870},{"date":"2024-05-31","current":-5.254478,"twenty":-5.016423,"median":-4.56334,"eighty":-4.196492,"marketCap":32011137},{"date":"2024-06-07","current":-5.573329,"twenty":-5.126143,"median":-4.595762,"eighty":-4.217405,"marketCap":33953631},{"date":"2024-06-14","current":-5.672448,"twenty":-5.245388,"median":-4.604954,"eighty":-4.217405,"marketCap":34557478},{"date":"2024-06-21","current":-5.254478,"twenty":-5.254478,"median":-4.639973,"eighty":-4.217405,"marketCap":32011137},{"date":"2024-06-28","current":-5.553028,"twenty":-5.257507,"median":-4.639973,"eighty":-4.217405,"marketCap":33829952},{"date":"2024-07-05","current":-6.836793,"twenty":-5.380881,"median":-4.661859,"eighty":-4.222726,"marketCap":41650855},{"date":"2024-07-12","current":-8.120557,"twenty":-5.46684,"median":-4.674942,"eighty":-4.245731,"marketCap":49471758},{"date":"2024-07-15","current":-8.478817,"twenty":-5.484657,"median":-4.679369,"eighty":-4.24745,"marketCap":51654336},{"date":"2024-08-02","current":-10.568666,"twenty":-5.500483,"median":-4.681339,"eighty":-4.24917,"marketCap":64386038},{"date":"2024-08-09","current":-8.299687,"twenty":-5.526159,"median":-4.683746,"eighty":-4.266453,"marketCap":50563047},{"date":"2024-08-16","current":-8.419107,"twenty":-5.589093,"median":-4.694558,"eighty":-4.282332,"marketCap":51290573},{"date":"2024-08-23","current":-7.881717,"twenty":-5.717813,"median":-4.727519,"eighty":-4.286974,"marketCap":48016706},{"date":"2024-08-30","current":-6.896503,"twenty":-6.017985,"median":-4.738462,"eighty":-4.287114,"marketCap":42014618},{"date":"2024-09-06","current":-6.329258,"twenty":-6.201587,"median":-4.792698,"eighty":-4.288183,"marketCap":38558870},{"date":"2024-09-13","current":-7.045778,"twenty":-6.309738,"median":-4.815066,"eighty":-4.296814,"marketCap":42924025},{"date":"2024-09-20","current":-5.76261,"twenty":-6.309738,"median":-4.815066,"eighty":-4.313201,"marketCap":35106760},{"date":"2024-09-27","current":-5.791271,"twenty":-6.293445,"median":-4.845774,"eighty":-4.331833,"marketCap":35281366},{"date":"2024-10-04","current":-5.494176,"twenty":-6.293445,"median":-4.868142,"eighty":-4.350567,"marketCap":40171894},{"date":"2024-10-11","current":-4.148845,"twenty":-6.216784,"median":-4.858839,"eighty":-4.350567,"marketCap":30335209},{"date":"2024-10-18","current":-4.157755,"twenty":-6.122441,"median":-4.845774,"eighty":-4.288183,"marketCap":30400352},{"date":"2024-10-25","current":-4.212202,"twenty":-6.099645,"median":-4.815066,"eighty":-4.286905,"marketCap":30798452},{"date":"2024-10-31","current":-4.032032,"twenty":-6.085858,"median":-4.815066,"eighty":-4.286835,"marketCap":29481103},{"date":"2024-11-08","current":-3.964716,"twenty":-6.030708,"median":-4.792698,"eighty":-4.245731,"marketCap":28988907},{"date":"2024-11-15","current":-4.157755,"twenty":-6.026467,"median":-4.727519,"eighty":-4.217405,"marketCap":30400352},{"date":"2024-11-22","current":-3.652759,"twenty":-6.001802,"median":-4.723303,"eighty":-4.18255,"marketCap":32209897},{"date":"2024-11-29","current":-4.656782,"twenty":-5.970998,"median":-4.694558,"eighty":-4.18255,"marketCap":41063331},{"date":"2024-12-06","current":-5.005528,"twenty":-5.961427,"median":-4.719087,"eighty":-4.18255,"marketCap":44138559},{"date":"2024-12-13","current":-5.066661,"twenty":-5.907942,"median":-4.727519,"eighty":-4.18255,"marketCap":44677628},{"date":"2024-12-20","current":-4.513181,"twenty":-5.895445,"median":-4.727519,"eighty":-4.18255,"marketCap":39797061},{"date":"2024-12-27","current":-4.800383,"twenty":-5.891211,"median":-4.759354,"eighty":-4.202312,"marketCap":42329601},{"date":"2025-01-03","current":-4.595649,"twenty":-5.831182,"median":-4.759354,"eighty":-4.210222,"marketCap":40524262},{"date":"2025-01-10","current":-4.55421,"twenty":-5.791868,"median":-4.759354,"eighty":-4.214283,"marketCap":40158853},{"date":"2025-01-17","current":-4.808589,"twenty":-5.791868,"median":-4.765324,"eighty":-4.217405,"marketCap":42401960},{"date":"2025-01-24","current":-4.841412,"twenty":-5.791749,"median":-4.765324,"eighty":-4.217405,"marketCap":42691393},{"date":"2025-01-31","current":-4.595239,"twenty":-5.790189,"median":-4.759354,"eighty":-4.217405,"marketCap":40520644},{"date":"2025-02-07","current":-4.718325,"twenty":-5.781211,"median":-4.75438,"eighty":-4.222726,"marketCap":41606019},{"date":"2025-02-14","current":-4.636268,"twenty":-5.75842,"median":-4.727519,"eighty":-4.245731,"marketCap":40882436},{"date":"2025-02-21","current":-6.113309,"twenty":-5.785861,"median":-4.749406,"eighty":-4.252608,"marketCap":53906929},{"date":"2025-02-28","current":-3.938776,"twenty":-5.785861,"median":-4.75438,"eighty":-4.252608,"marketCap":34731981},{"date":"2025-03-07","current":-4.061863,"twenty":-5.76261,"median":-4.727519,"eighty":-4.217405,"marketCap":35817355},{"date":"2025-03-14","current":-4.184949,"twenty":-5.741662,"median":-4.718911,"eighty":-4.212202,"marketCap":36902729},{"date":"2025-03-21","current":-3.781635,"twenty":-5.692164,"median":-4.717095,"eighty":-4.184949,"marketCap":33346319},{"date":"2025-03-28","current":-3.800136,"twenty":-5.672448,"median":-4.683746,"eighty":-4.18255,"marketCap":33646606},{"date":"2025-04-04","current":-3.839558,"twenty":-5.66199,"median":-4.683746,"eighty":-4.157755,"marketCap":33995653},{"date":"2025-04-11","current":-3.717019,"twenty":-5.653341,"median":-4.678332,"eighty":-4.145266,"marketCap":32910685},{"date":"2025-04-17","current":-3.41639,"twenty":-5.652863,"median":-4.673905,"eighty":-4.117991,"marketCap":30248898},{"date":"2025-04-21","current":-3.241379,"twenty":-5.652744,"median":-4.670514,"eighty":-4.117325,"marketCap":28699347}],"updateTime":1745344633746}}}